Protective effects of Angelica sinensis polysaccharides on acetic acid-induced rat colitis

World Chinese Journal of Digestology

Volumn 12, Issue 2, 2004, Pages 367-370

  Liu, Shao Ping ^a   Dong, Wei Guo ^a   Yu, Bao Ping ^a   Luo, He Sheng ^a   Yu, Jie Ping ^a   Wu, Dong Fang ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ANGELICA SINENSIS EXTRACT; ENEMA; EOSIN; GROWTH FACTOR; HEMATOXYLIN; MYELOPEROXIDASE; NITRIC OXIDE; OXYGEN RADICAL; POLYSACCHARIDE; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ANGELICA SINENSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COLITIS; COLON INJURY; COLON MUCOSA; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; NONHUMAN; OCCULT BLOOD TEST; PROTECTION; PROTEIN EXPRESSION; RAT;

EID: 1942441638     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: 10.11569/wcjd.v12.i2.367     Document Type: Article

References (37)

1. Xie L, Yang LH, Li XH. Resarch on the pharmacologic effects of Angelica sinensis. Res Tradi Chin Med 2000;16:56-58
2. Ye YN, Koo MW, Li Y, Matsui H, Cho CH. Angelica sinensis modulates migration and proliferation of gastric epithelial cells. Life Sci 2001;68:961-968
3. Ye YN, Liu ES, Shin VY, Koo MW, Li Y, Wei EQ, Matsui H, Cho CH. A mechanistic study of proliferation induced by Angelica sinensis in a normal gastric epithelial cell line. Biochem Pharmacol 2001;61:1439-1448
4. Cho CH, Mei QB, Shang P, Lee SS, So HL, Guo X, Li Y. Study of the gastrointestinal protective effects of polysaccharides from Angelica sinensis in rats. Plant Med 2000;66:348-351
5. Ye YN, Liu ES, Li Y, So HL, Cho CC, Sheng HP, Lee SS, Cho CH. Protective effect of polysaccharides-enriched fraction from Angelica sinensis on hepatic injury. Life Sci 2001;69:637-646
6. Ding H, Peng R, Yu J. Modulation of Angelica sinensis polysaccharideson the expression of nitric oxide synthase and Bax, Bcl-2 in liver of immunological liver-injured mice. Zhonghua Ganzangbing Zazhi 2001;9(Suppl):50-52
7. Ye YN, So HL, Liu ES, Shin VY, Cho CH. Effect of polysaccharides from Angelica sinensis on gastric ulcer healing. Life Sci 2003;72:925-932
8. Millar AD, Rampton DS, Chander CL, Claxson AW, Blades S, Coumbe A, Panetta J, Morris CJ, Blake DR. Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colits. Gut 1996;39:93-99
9. Li L, Wang ZL, Ke JT, Zhang M, Shao JF, Zhong CN. Select animal models for experimental colitis model. Shijie Huaren Xiaohua Zazhi 2001;9:584-585
10. Li JH, Yu JP, He XF, Xu XM. Expression of NF-κB in rats with TNBS-induced ulcerative colitis. Shijie Huaren Xiaohua Zazhi 2003;11:214-218
11. Krieglstein CF, Cerwinka WH, Laroux FS, Salter JW, Russell JM, Schuermann G, Grisham MB, Ross CR, Granger DN. Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: divergent roles of superoxide and nitric oxide. J Exp Med 2001;194:1207-1218
12. Kirsner JB. Historical origins of current IBD concepts. World J Gastroenterol 2001;7:175-184
13. Pavlick KP, Laroux FS, Fuseler J, Wolf RE, Gray L, Hoffman J, Grisham MB. Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease. Free Radic Biol Med 2002;33:311-322
14. Huycke MM, Abrams V, Moore DR. Enterococus faecalis produces extracellular superoxide and hydrogen peroxide that damages colonic epithelial cell DNA. Carcinogenesis 2002;23: 529-536
15. 2 on visceral angiectasis in portal hypertension. Shijie Huaren Xiaohua Zazhi 2000;8:1154-1156
16. Le QL, Wen XD. The role of nitric oxide in stress-induced gastric ulcers in rats. Shijie Huaren Xiaohua Zazhi 2000;8:815-816
17. Wang QG, He LY, Chen YW, Hu LS. Enzymohistochemical study on burn effect on rat intestinal NOS. World J Gastroenterol 2000;6:421-423
18. Bai AP, Shen ZX, Yu JP, Yu BP, Luo Y. Nitric oxide and the acute injury in colitis model. Shijie Huaren Xiaohua Zazhi 1999; 7:900-901
19. Yavuz Y, Yuksel M, Yegen BC, Alican I. The effect of antioxidant therapy on colonic inflammation in the rat. Res Exp Med (Berl) 1999;199:101-110
20. Zhang K, Deng CS, Zhu YQ, Yang YP, Zhang YM. Signifisance of nuclear factor-κB, cyclooxygenase-2 and inducible nitric oxide synthase expression in human ulcerative colitis tissues. Shijie Huaren Xiaohua Zazhi 2002;10:575-578
21. Yamamoto Y, Gaynor RB. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Invest 2001;107:135-142
22. Liu SQ, Yu JP, Luo HS, Ran ZX. Effects of Ginkgo biloba extract on expression of NF-κB in rat liver fibrosis. Shijie Huaren Xiaohua Zazhi 2002;10:922-926
23. Sporn MB, Roberts AB. Transforming growth factor-beta:recent progress and new challenges. J Cell Biol 1992;199:1017-1021
24. Higasshiyama S, Abraham JA, Miller J, Fiddes JC, Klagsbrun M. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 1991;251:932-943
25. Fu XB, Yang YH, Sun TZ, Gu XM, Jiang LX, Sun XQ, Sheng ZY. Effect of intestinal ischemia-reperfusion on expressions of endogenous basic fibroblast growth factor and transforming growth factor β in lung and its relation with lung repair. World J Gastroenterol 2000;6:353-355
26. Yuan YZ, Lou KX, Gong ZH, Tu SP, Zhai ZK, Xu JY. Effects and mechanisms of emodin on pancreatic tissue EGF expression in acute pancreatitis in rats. Shijie Huaren Xiaohua Zazhi 2001;9:127-130
27. 1, and PDGF-A expression in gastric cancer tissue and prognosis. Shijie Huaren Xiaohua Zazhi 2002;10:36-39
28. 1 and TGF-β receptor in gastric carcinoma and precarcerous lesions. Shijie Huaren Xiaohua Zazhi 1999;7:507-509
29. Banan A, Fields JZ, Talmage DA, Zhang L, Keshavarzian A. PKC-zeta is required in EGF protection of microtubules and intestinal barrier integrity against oxidant injury. Am J Physiol Gastrointest Liver Physiol 2002;282:G794-808
30. Banan A, Fields JZ, Zhang Y, Keshavarzian A. Phospholipase C-gamma inhibition prevents EGF protection of intestinal cytoskeleton and barrier against oxidants. Am J Physiol Gastrointest Liver Physiol 2001;281:G412-423
31. Banan A, Zhang Y, Losurdo J, Keshavarzian A. Carbonylation and disassembly of the F-actin cytoskeleton in oxidant induced barrier dysfunction and its prevention by epidermal growth factor and transforming growth factor alpha in a human colonic cell line. Gut 2000;46:830-837
32. Banan A, Fields JZ, Talmage DA, Zhang Y, Keshavarzian A. PKC-beta1 mediates EGF protection of microtubules and barrier of intestinal monolayers against oxidants. Am J Physiol Gastrointest Liver Physiol 2001;281:G833-847
33. Hahm KB, Im YH, Parks TW, Park SH, Markowitz S, Jung HY, Green J, Kim SJ. Loss of transforming growth factor beta signalling in the intestine contributes to tisse injury in inflammatory bowel disease. Gut 2001;49:190-198
34. Beck PL, Podolsky DK. Growth factors in inflammatory bowel disease. Inflamm Bowel Dis 1999;5:44-60
35. Sandborn WJ, Targan SR. Biologic therapy of inflammatory bowel disease. Gastroenterology 2002;122:1592-1608
36. Wiercinska-Drapalo A, Flisiak R, Prokopowicz D. The role of transforming growth factors beta in pathogenesis of ulcerative colitis. Pol Merkuriusz Lek 2001;10:177-179
37. Whiting CV, Williams AM, Claesson MH, Bregenholt S, Reimann J, Bland PW. Transforming growth factor-beta messenger RNA and protein in murine colitis. J Histochem Cytochem 2001;49:727-738